Cargando…
Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β(2)-agonist use
Autores principales: | Nayak, AS, Nathan, RA, Meltzer, EO, Weinstein, SF, Nolte, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242176/ http://dx.doi.org/10.1186/1710-1492-7-S2-A15 |
Ejemplares similares
-
Reduction in asthma deteriorations in subjects with persistent asthma uncontrolled on low-, medium-, or high-dose inhaled corticosteroids: a pooled analysis from three clinical trials using combined mometasone furoate/formoterol
por: Weinstein, SF, et al.
Publicado: (2011) -
Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
por: Pearlman, David, et al.
Publicado: (2011) -
Asthma control using a combination of mometasone furoate/formoterol: grouped analysis of three clinical trials
por: White, Martha, et al.
Publicado: (2011) -
190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma
por: Pearlman, David, et al.
Publicado: (2012) -
191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol
por: Murphy, Kevin, et al.
Publicado: (2012)